Dexcom Inc., US2521311074

Dexcom stock slips 2.01 percent ahead of the open

Published on 09/25/2026 at 03:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 24, 2026, Dexcom stock stood at USD 87.73 after a 2.01 percent decline; the Nasdaq Composite added 3.34 points to 26,939.37.

Fotorealistischer CGM-Sensor-Patch am Arm, klinisches Umfeld, Medizintechnik
Dexcom Inc. zeigt fotorealistischen CGM-Sensor am Unterarm für Anleger mit ISIN US2521311074 Medizintechnik, Illustration mit AI erstellt.

Dexcom stock closed at USD 87.73 on the Nasdaq on September 24, 2026, down 2.01 percent from the prior close. The Nasdaq Composite rose 3.34 points, or less than 0.1 percent, to 26,939.37, leaving Dexcom behind its reference index in the same session.

September 24, 2026 in numbers

DexCom, Inc. (ISIN US2521311074, Nasdaq: DXCM) traded between USD 86.90 and USD 89.10 on September 24, 2026. Its 12-month range was USD 54.11 to USD 92.59, placing the close USD 4.86 below the 12-month high and USD 33.62 above the low.

As TipRanks reported on September 24, 2026, Truist Financial maintained a Buy rating and a USD 102.00 price target for Dexcom. That target stood USD 14.27 above the September 24, 2026 close.

September 25, 2026 market cues

US markets have scheduled economic releases on September 25, 2026, including durable-goods data and the final University of Michigan consumer-sentiment reading. Investing.com identified durable-goods orders as a key release for the session.

Disclaimer...

en | US2521311074 | DEXCOM INC. | boerse | 70180197 | bgmi